CCL2 and cancer: LINC00337 promotes CCL2, IL-13, and M-CSF secretion inducing macrophage recruitment and M2 polarization, as demonstrated by the upregulation of the M2 markers CD163 and ARGM2 macrophages, which then increase the malignant behavior of chemo-resistant cancer cells by promoting their survival and migratory abilities [80].